Prot# 1160.26: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate with Open-Label Warfarin for the Prevention of Stroke and Systemic Embolism inPatients

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/0612/1/11

Funding

  • Boehringer Ingelheim International GmbH (1160.26)